Cover Image

Anti-Müllerian hormone is correlated with cumulative live birth in minimal ovarian stimulation with clomiphene citrate: a retrospective cohort study

Abstract Background Several studies have investigated the correlation between the serum anti-Müllerian hormone (AMH) level and in vitro fertilization (IVF) outcomes in controlled ovarian stimulation cycles; however, studies regarding the correlation of the serum AMH level with IVF outcomes in minim...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kenji Ezoe (Author), Xiaowen Ni (Author), Tamotsu Kobayashi (Author), Keiichi Kato (Author)
Format:	Book
Published:	BMC, 2020-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The role of anti-Mullerian hormone in predicting the response to clomiphene citrate in unexplained infertility
by: Bora Coskun, et al.
Published: (2018)

Characteristics of the cytoplasmic halo during fertilisation correlate with the live birth rate after fresh cleaved embryo transfer on day 2 in minimal ovarian stimulation cycles: a retrospective observational study
by: Kenji Ezoe, et al.
Published: (2021)

Metformin-clomiphene citrate vs. clomiphene citrate alone: Polycystic ovarian syndrome
by: Aqueela Ayaz, et al.
Published: (2013)

Association of anti-mullerian hormone and free androgen index level on response to clomiphene citrate in PCOS infertile women
by: Jasmine Kavitha Washington, et al.
Published: (2022)

Combination of pioglitazone and clomiphene citrate versus clomiphene citrate alone for infertile women with the polycystic ovarian syndrome
by: Maliheh Amirian, et al.
Published: (2021)

Comparison of the effects of Ginger extract with clomiphene citrate on sex hormones in rats with polycystic ovarian syndrome
by: Shekoufeh Atashpour, et al.
Published: (2017)

Metformin With or Without Clomiphene Citrate Versus Laparoscopic Ovarian Drilling With or Without Clomiphene Citrate to Treat Patients With Clomiphene Citrate-Resistant Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis
by: Ming-Li Sun, et al.
Published: (2022)

Comparison of clinical, metabolic, hormonal, and ultrasound parameters among the clomiphene citrate-resistant and clomiphene citrate-sensitive polycystic ovary syndrome women
by: Garima Sachdeva, et al.
Published: (2019)

A study of controlled ovarian stimulation with clomiphene citrate or letrozole in combination with gonadotropins and IUI in unexplained infertility
by: Madhusmita Hembram, et al.
Published: (2017)

Progestin-primed ovarian stimulation protocol with or without clomiphene citrate for poor ovarian responders: a retrospective cohort study
by: Ahui Liu, et al.
Published: (2022)

Statement of Retraction: Minimal stimulation or clomiphene citrate as first-line therapy in women with polycystic ovary syndrome: a randomized controlled trial
Published: (2024)

The efficacy of metformin and clomiphene citrate combination compared with clomiphene citrate alone for ovulation induction in infertile patients with PCOS
by: Papa Dasari, et al.
Published: (2009)

Age and anti-Műllerian hormone: prediction of cumulative pregnancy outcome in in vitro fertilization with diminished ovarian reserve
by: Yu Deng, et al.
Published: (2021)

Minimal ovarian stimulation combined with elective single embryo transfer policy: age-specific results of a large, single-centre, Japanese cohort
by: Kato Keiichi, et al.
Published: (2012)

Association between endometrial thickness before ovulation, live birth, and placenta previa rates in clomiphene citrate-treated cyclesAJOG Global Reports at a Glance
by: Shogo Nishii, MD, PhD, et al.
Published: (2023)

Low dose clomiphene citrate as a mild stimulation protocol in women with unsuspected poor in vitro fertilization result can generate more oocytes with optimal cumulative pregnancy rate
by: Humphrey Ochin, et al.
Published: (2018)

Progestin-Primed Ovarian Stimulation with Clomiphene Citrate Supplementation May Be More Feasible for Young Women with Diminished Ovarian Reserve Compared with Standard Progestin-Primed Ovarian Stimulation: A Retrospective Study
by: Lin Y, et al.
Published: (2021)

A cumulative strategy of GnRH agonist, clomiphene citrate, and GnRH antagonist in a patient with recurrent endometriosis and repeated aspiration
by: Su-Long Lee, et al.
Published: (2011)

Comparative effectiveness of sildenafil citrate and estradiol valerate as adjuvants during clomiphene citrate-assisted ovarian stimulation cycles in patients with unexplained infertility: a double-blind randomized controlled trial
by: Jean-Didier B, et al.
Published: (2024)

Progestin-primed milder stimulation with clomiphene citrate yields fewer oocytes and suboptimal pregnancy outcomes compared with the standard progestin-primed ovarian stimulation in infertile women with polycystic ovarian syndrome
by: Hongjuan Ye, et al.
Published: (2018)

Clomiphene citrate plus letrozole versus clomiphene citrate alone for ovulation induction in infertile women with ovulatory dysfunction: a randomized controlled trial
by: Pattraporn Chera-aree, et al.
Published: (2023)

Clomiphene Citrate Challenge Test and Prediction of Outcome in IVF
by: Azizeh Ghaseminejad, et al.
Published: (2008)

Heterotopic pregnancy following induction of ovulation with clomiphene citrate
by: Sedigheh Ghandi, et al.
Published: (2011)

Metformin-letrozole in comparison with Metformin-clomiphene citrate in clomiphene-resistance PCOS patients undergoing IUI
by: Mohammad Hossein Fallahzadeh, et al.
Published: (2011)

The cumulative live birth rate of recombinant follicle-stimulating hormone alfa verse urinary human follicle-stimulating hormone for ovarian stimulation in assisted reproductive technology cycles
by: Chunxia Yang, et al.
Published: (2022)

Letrozole versus Clomiphene Citrate for Induction of Ovulation in Patients with Polycystic Ovarian Syndrome Undergoing Intrauterine Insemination
by: Sherif F. Hendawy, et al.
Published: (2011)

Effect of clomiphene citrate on uterine hemodynamics in women with unexplained infertility
by: Omran E, et al.
Published: (2018)

Severe thrombocytopenia and maculoerythematous rash associated with clomiphene citrate use
by: Said Abuhasna, et al.
Published: (2011)

Clomiphene based ovarian stimulation in a commercial donor program
by: Shruti Gupta, et al.
Published: (2015)

Cumulative cyclophosphamide dose and serum anti-Mullerian hormone levels in adolescent cancer survivors in Indonesia
by: Sri Mulatsih, et al.
Published: (2023)

A prospective randomized trial comparing the efficacy of Letrozole and Clomiphene citrate in induction of ovulation in polycystic ovarian syndrome
by: Kallol Kumar Roy, et al.
Published: (2012)

Ovulation rates in a stair-step protocol with Letrozole vs clomiphene citrate in patients with polycystic ovarian syndrome
by: S. Thomas, et al.
Published: (2019)

Anti-mullerian hormone cut-off values for predicting poor ovarian response to exogenous ovarian stimulation in in-vitro fertilization
by: Ruma Satwik, et al.
Published: (2012)

Inter-cycle variability of anti-Müllerian hormone: implications for predicting controlled ovarian stimulation cycle outcomes
by: Yavuz Emre Şükür, et al.
Published: (2024)

Effects of clomiphene citrate plus estradiol or progesterone on endometrial ultrastructure: An RCT
by: Robabeh Taheripanah, et al.
Published: (2020)

Letrozole or clomiphene citrate as first line for anovulatory infertility: a debate
by: George Korula, et al.
Published: (2011)

Acute myocardial infarction associated with clomiphene citrate in a young woman
by: Şahin Avşar, et al.
Published: (2018)

Pregnancy outcome in women with polycystic ovary syndrome comparing the effects of laparoscopic ovarian drilling and clomiphene citrate stimulation in women pre-treated with metformin: a retrospective study
by: Vytiska-Binstorfer Elisabeth, et al.
Published: (2010)

Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study
by: Xi W, et al.
Published: (2015)

An Ovarian Reserve Assessment Model Based on Anti-Müllerian Hormone Levels, Follicle-Stimulating Hormone Levels, and Age: Retrospective Cohort Study
by: Xu, Huiyu, et al.
Published: (2020)